Clinical Aspects of Intravenous Immunoglobulin Use in Solid Organ Transplant Recipients
Open Access
- 1 February 2011
- journal article
- review article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 11 (2), 196-202
- https://doi.org/10.1111/j.1600-6143.2010.03400.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantationThe Journal of Heart and Lung Transplantation, 2010
- Advances in diagnosing and managing antibody-mediated rejectionPediatric Nephrology, 2010
- Intravenous immunoglobulins – understanding properties and mechanismsClinical and Experimental Immunology, 2009
- Excellent Renal Allograft Survival in Donor-Specific Antibody Transplant Patients—Role of Intravenous Immunoglobulin and Rabbit Antithymocyte GlobulinTransplantation, 2009
- Intravenous Immunoglobulin a Natural Regulator of Immunity and InflammationTransplantation, 2009
- Rituximab and Intravenous Immune Globulin for Desensitization during Renal TransplantationNew England Journal of Medicine, 2008
- Common variable immune deficiency and autoimmunityAutoimmunity Reviews, 2006
- Safety and Adverse Events Profiles of Intravenous Gammaglobulin Products Used for ImmunomodulationClinical Journal of the American Society of Nephrology, 2006
- Utility of Peritransplant and Rescue Intravenous Immunoglobulin and Extracorporeal Immunoadsorption in Lung Transplant Recipients Sensitized to HLA AntigensHuman Immunology, 2005
- LONG-TERM BENEFIT OF INTRAVENOUS IMMUNOGLOBULINS IN CADAVERIC KIDNEY RETRANSPLANTATIONTransplantation, 1996